Gemmothérapie Vessie / Pangguang complément alimentaire
Food supplement declared in France, declaration No 2020-6-34, decision dated 1 June 2020
Gemmothérapie Vessie / Pangguang complément alimentaire (MERYSTEME) is a food supplement declared in France. Status: declared in France, may be marketed. Main ingredients: Vaccinium vitis-idaea 358 mg per day, Calluna vulgaris 358 mg per day, Populus nigra 358 mg per day, Sequoiadendron giganteum 358 mg per day. 1 rule of use applies to its ingredients (limits and warnings).
- Brand
- MERYSTEME
- Food business operator placing the product on the market
- MERYSTEME
- Status
- Declared in France, may be marketed: the authorities did not object to the declaration (this is neither an authorisation nor a safety assessment)
- Form
- Bottle
- Daily dose
- 30 gouttes
- Directions for use
- 5 à 15 gouttes 2 fois par jour pendant 21 jours
- Not recommended (according to the manufacturer)
- Adolescents (under 18), Breastfeeding women, Allergy to salicylate derivatives, Children (under 12), Pregnant women, Taking anticoagulants
Declaration 316329, procedure Article 16. Compl'Alim, food supplement declarations (France), retrieved 15 November 2026.
Declared composition
Plants
| Plant | Part | Preparation | Per day |
|---|---|---|---|
| Vaccinium vitis-idaea L. | Jeune pousse | Autre extrait fluide | 358 mg |
| Calluna vulgaris (L.) Hull | Jeune pousse | Autre extrait fluide | 358 mg |
| Populus nigra L. | Bourgeon | Autre extrait fluide | 358 mg |
| Sequoiadendron giganteum (Lindl.) J.Buchholz | Jeune pousse | Autre extrait fluide | 358 mg |
List from the declaration, administrative decision dated (Compl'Alim, food supplement declarations (France)).
Label warnings
L'emploi chez les enfants et les adolescents chez les personnes souffrant d'allergies aux dérivés salicylés et chez les personnes sous traitement anti-coagulant est déconseillé. Déconseillé aux femmes enceintes et allaitantes. Tenir hors de portée des enfants.
Regulatory points
- Conditions légales
Vaccinium vitis-idaea L.: L'étiquetage doit comporter un avertissement déconseillant l'emploi aux femmes enceintes.
Source: French orders of 9 May 2006 (nutrients), 24 June 2014 (plants) and 26 September 2016 (other substances), consolidated LEGI collection, arrêté du 24 juin 2014, annexe I.
This information reproduces the manufacturer's declaration to the administration (DGAL). It does not say whether the product is effective and does not replace advice from a doctor or pharmacist, particularly during pregnancy or when taking medication.
Brand : MERYSTEME
Is something on this product wrong or out of date, whether you are a reader or the brand? Write to contact@compoatlas.com: every correction is published in the corrections log.
Cite this page: CompoAtlas, “Gemmothérapie Vessie / Pangguang complément alimentaire (MERYSTEME): composition and regulation”, https://compoatlas.com/en/supplements/products/316329-gemmotherapie-vessie-pangguang-complement-alimentaire, updated 15 November 2026.